AutonoMe
Showing 1 - 5 of 5
CLASSICA: Validating AI in Classifying Cancer in Real-Time
Not yet recruiting
- Rectum Neoplasm
- +2 more
-
Dublin, Other (Non U.s.), IrelandMater Misericordiae University Hospital
Mar 20, 2023
Clareon® IOL AutonoMe™ in Japanese Subjects
Completed
- Cataract
- Clareon® IOL AutonoMe™ automated preloaded delivery system
-
Yokohama, Kanagawa, Japan
- +2 more
Mar 9, 2021
Cataract Senile, Myopia, High-Grade, Corneal Astigmatism Trial in Moscow (IOL Clareon AutonoMe, IOL Hoya iSert 251)
Recruiting
- Cataract Senile
- +2 more
- IOL Clareon AutonoMe
- IOL Hoya iSert 251
-
Moscow, Russian FederationThe S. N. Fyodorov Eye Microsurgery Federal State Institution
Nov 24, 2021
Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)
Not yet recruiting
- Aphakia
- Clareon Vivity/Vivity Toric Extended Vision IOL
- Clareon/Clareon Toric Aspheric IOL
-
Torrance, California
- +6 more
May 2, 2023
EGFR Positive NSCLC, Adenocarcinoma Trial in China (Sequential Icotinib Plus Chemotherapy, Icotinib)
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Sequential Icotinib Plus Chemotherapy
- Icotinib
-
Lanzhou, Gansu, China
- +30 more
Apr 27, 2015